US 8501705
Methods and materials for treating autoimmune and/or complement mediated diseases and conditions
granted A61KA61K2039/505A61K31/713
Quick answer
US patent 8501705 (Methods and materials for treating autoimmune and/or complement mediated diseases and conditions) held by The Board of Regents of the University of Texas System expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K2039/505, A61K31/713, A61P, A61P29/00